Watmind USA’s serology diagnostic products such as its M2 and M5 are the world’s first portable microfluidic chemiluminescence quantitative serology machines that test for COVID-19, including the combination of IgM, IgG, Total Antibody, and Viral Antigen.
Watmind USA’s equipment already has the full approval of the National Medical Products Administration (NMPA), China’s equivalent of the FDA, a full European CE mark and is now under evaluation for emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) for the disposable test kits, with applications to follow for the M2 and M5 machines. The company’s equipment holds more than 50 patents.
Watmind USA’s equipment was deployed at “ground zero” of the COVID-19 pandemic in China and Europe.
Watmind USA was created in response to unprecedented demand as the pandemic spread from China and Europe to the United States. Now headquartered in Austin, Texas, a majority of its team is running COVID-19 field operations in New York, Florida, Arizona, Mississippi, Missouri and California.
Company’s Keywords:
<0
<
<2020
Your request has been submitted successfully.
Own or work here?